<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Drug Development on The FIVE Institute</title><link>https://five-meo.education/topics/drug-development/</link><description>Recent content in Drug Development on The FIVE Institute</description><generator>Hugo</generator><language>en-us</language><lastBuildDate>Mon, 14 Sep 2026 17:00:00 -0700</lastBuildDate><atom:link href="https://five-meo.education/topics/drug-development/index.xml" rel="self" type="application/rss+xml"/><item><title>Non-Hallucinogenic 5-MeO-DMT: Neuroplasticity, Brain Repair &amp; Psychedelic Medicine</title><link>https://five-meo.education/seminars/non-hallucinogenic-5-meo-dmt-neuroplasticity/</link><pubDate>Mon, 14 Sep 2026 17:00:00 -0700</pubDate><guid>https://five-meo.education/seminars/non-hallucinogenic-5-meo-dmt-neuroplasticity/</guid><description>Neuroscientists Manesh Girn and Lindsay Cameron ask whether the neuroplastic effects of 5-MeO-DMT can be separated from the psychedelic experience.</description></item></channel></rss>